Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries

De Kraker, Marlieke

doi:10.1371/journal.pmed.1004262

Scientific article

Comment

English

Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries

ContributorsDe Kraker, Marlieke

Published inPLoS medicine, vol. 20, no. 7, e1004262

Publication date2023-07

First online date2023-07-12

Abstract

Marlieke de Kraker discusses a systematic review and meta-analysis reporting the magnitude and consequences of bloodstream infections in low- and middle-income countries.

Keywords

Humans
Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Developing Countries
Drug Resistance, Bacterial
Sepsis / drug therapy
Systematic Reviews as Topic
Meta-Analysis as Topic

NoteComment on : Allel K, Stone J, Undurraga EA, Day L, Moore CE, Lin L, Furuya-Kanamori L, Yakob L. The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis. PLoS Med. 2023 Jun 22;20(6):e1004199. doi: 10.1371/journal.pmed.1004199.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Résistance aux antibiotiques (866)

Citation (ISO format)

DE KRAKER, Marlieke. Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries. In: PLoS medicine, 2023, vol. 20, n° 7, p. e1004262. doi: 10.1371/journal.pmed.1004262